Renda sells SUPN 8.48: Supernus Pharmaceuticals (SUPN) Scheduled to Post Earnings on Monday
Supernus Pharmaceuticals (NASDAQ:SUPN) is set to post its Q214 quarterly earnings results on Monday, August 11th. Analysts expect Supernus Pharmaceuticals to post earnings of ($0.16) per share and revenue of $19.85 million for the quarter. Shares of ... ...
39 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home